Similarly, in METTL3 deletion acute myeloid leukemia (AML) cells, c-MYC, BCL2, and PTEN protein expression were reduced despite a 2–5 log2-fold increase in mRNA expression51. This evidence concerns the gene BCL2 and acute myeloid leukemia.